Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. (LRMR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LRMR · as of Jun 8, 2026
Key Statistics
Explore Larimar Therapeutics, Inc. Data
lrmr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
The LRMR analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +287.10% upside from the current price of $3.10.
Competitors & Peers
lrmr competitorsLRMR
ACIU
ALT
AMRN
ANNX
ANROStock Performance
Full HistoryAbout Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a dis…
what is larimar therapeutics, inc. · lrmr stock overview · larimar therapeutics, inc. company profile · who is larimar therapeutics, inc. ceo · lrmr NASDAQ · larimar therapeutics, inc. headquarters · larimar therapeutics, inc. business segments
About Stock Overview & Key Data
Larimar Therapeutics, Inc. (LRMR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 19, 2014. As of the latest trading session, LRMR stock price is $3.10, with a market capitalization of $265.3M. The stock has returned +18.98% over the past 12 months and -16.93% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Larimar Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Larimar Therapeutics, Inc. reported revenue of — and net income of -$165.7M. For detailed data — including Larimar Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Larimar Therapeutics, Inc. (LRMR) stock price is $3.10. The stock is traded on NASDAQ under the ticker symbol LRMR. The 52-week range is $2.22 – $6.42.